Literature DB >> 16449508

Role of drug eluting stents in diabetic patients.

F Boccara, E Teiger, A Cohen.   

Abstract

There is a clear need for a large multicentre trial comparing the efficacy of the two available drug eluting stents, sirolimus and paclitaxel, in diabetic patients with multivessel disease.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16449508      PMCID： PMC1860933          DOI： 10.1136/hrt.2005.082172

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  16 in total

1.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

Authors:  E Van Belle; C Bauters; E Hubert; J C Bodart; K Abolmaali; T Meurice; E P McFadden; J M Lablanche; M E Bertrand
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

Review 2.  Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Authors:  C Stettler; S Allemann; M Egger; S Windecker; B Meier; P Diem
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Diabetes and decline in heart disease mortality in US adults.

Authors:  K Gu; C C Cowie; M I Harris
Journal:  JAMA       Date:  1999-04-14       Impact factor: 56.272

4.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

Authors:  Ioannis Iakovou; Thomas Schmidt; Erminio Bonizzoni; Lei Ge; Giuseppe M Sangiorgi; Goran Stankovic; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Mauro Carlino; Iassen Michev; Nicola Corvaja; Carlo Briguori; Ulrich Gerckens; Eberhard Grube; Antonio Colombo
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

5.  Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.

Authors:  Adnan Kastrati; Alban Dibra; Sonja Eberle; Julinda Mehilli; José Suárez de Lezo; Jean-Jacque Goy; Kurt Ulm; Albert Schömig
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

6.  Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

Authors:  Stephan Windecker; Andrea Remondino; Franz R Eberli; Peter Jüni; Lorenz Räber; Peter Wenaweser; Mario Togni; Michael Billinger; David Tüller; Christian Seiler; Marco Roffi; Roberto Corti; Gabor Sütsch; Willibald Maier; Thomas Lüscher; Otto M Hess; Matthias Egger; Bernhard Meier
Journal:  N Engl J Med       Date:  2005-08-16       Impact factor: 91.245

7.  Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients.

Authors:  Eric Van Belle; Marc Périé; David Braune; Akram Chmaït; Thibaud Meurice; Kaveh Abolmaali; Eugène P McFadden; Christophe Bauters; Jean-Marc Lablanche; Michel E Bertrand
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

8.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

Authors:  D R Holmes; R E Vlietstra; H C Smith; G W Vetrovec; K M Kent; M J Cowley; D P Faxon; A R Gruentzig; S F Kelsey; K M Detre
Journal:  Am J Cardiol       Date:  1984-06-15       Impact factor: 2.778

9.  Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

Authors:  Victor M G Legrand; Patrick W Serruys; Felix Unger; Ben A van Hout; Mathias C M Vrolix; Geert M P Fransen; Torsten Toftegaard Nielsen; Peter Kildeberg Paulsen; Ricardo Seabra Gomes; João M G de Queiroz e Melo; José P Marques dos Santos Neves; Wietze Lindeboom; Bianca Backx
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.